Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines
- 1 June 1999
- Vol. 53 (6) , 1252-1257
- https://doi.org/10.1016/s0090-4295(99)00033-3
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.Journal of Clinical Investigation, 1997
- Tumor Cell Nitric Oxide Inhibits Cell Growthin Vitro,but Stimulates Tumorigenesis and Experimental Lung Metastasisin VivoJournal of Surgical Research, 1996
- Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter.Proceedings of the National Academy of Sciences, 1996
- Roles of nitric oxide in tumor growth.Proceedings of the National Academy of Sciences, 1995
- Changes in urinary cytokines and soluble intercellular adhesion molecule-1 (ICAM-1) in bladder cancer patients after Bacillus Calmette—Guérin (BCG) immunotherapyClinical and Experimental Immunology, 1995
- Nitric oxide is an important mediator for tumoricidal activity in vivo.Proceedings of the National Academy of Sciences, 1994
- Nitric oxide synthases in mammalsBiochemical Journal, 1994
- Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthasesFEBS Letters, 1991
- Interleukin-2 production during intravesical bacille Calmette-Guerin therapy for bladder cancerClinical Immunology and Immunopathology, 1986
- Epidermal growth factor and the multiplication of cultured human epidermal keratinocytesNature, 1977